Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...

At close: November 8 at 4:00 PM EST ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

Relay Therapeutics Inc ( (RLAY)) has released its Q3 earnings. Here is a breakdown of the information Relay Therapeutics Inc presented to its investors. Relay Therapeutics Inc., a clinical-stage ...

Coya Therapeutics, Inc. ( (COYA)) has released its Q3 earnings. Here is a breakdown of the information Coya Therapeutics, Inc. presented to its investors. Coya Therapeutics, Inc. is a clinical ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The non-profit Digital Therapeutics Alliance (DTA) – working with clinical trials specialist Curebase – has drawn up the document to help encourage the development of DTx products and get them ...

In a recent move, Carl Dambkowski, Chief Medical Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), sold a significant amount of company stock, totaling over... Apogee (NASDAQ ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants Lawyer raises objections to 23andMe's proposed $30 million settlement, arguing it undermines arbitration ...